期刊文献+

八聚精氨酸修饰的载紫杉醇脂质体的制备工艺研究 被引量:4

Preparation process of R8-modified paclitaxel-loaded liposomes
原文传递
导出
摘要 目的研究八聚精氨酸(R8)修饰的载紫杉醇脂质体的制备工艺。方法采用有机相反应法,将R8修饰到脂质体表面,并以薄膜分散-探头超声法制备载紫杉醇脂质体,以细胞摄取、粒径、PDI、包封率为主要指标对磷脂/胆固醇、药脂比、水化液种类、R8密度、DSPE-PEG2000密度进行筛选,进一步优化处方。结果最优处方为磷脂-胆固醇2∶1、药脂比1∶40、水化液为PBS(pH6.5)、R8密度5%、DSPE-PEG2000密度3%,所制脂质体的粒径为156±2 nm,PDI=0.25,包封率为80.87%±8.9%。结论成功制备了八聚精氨酸(R8)修饰的载紫杉醇脂质体。 OBJECTIVE To fabricate a novel liposomal formulation of paclitaxel modified with octaarginine(R8).METHODS R8 was modified onto the surface of liposomes by organic-phase reaction.The liposomes were prepared by thin film-ultrasonic method.The formulation was optimized by means of single-factor experiments with cellular uptake,entrapment efficiency,particle size and PDI as the factors to determine phospholipids-cholesterol,the ratio of drug to lipid,the hydration solution,the density of R8 and the density of DSPE-PEG2000.RESULTS The optimal formulation was that phospholipids-cholesterol(2:1),the ratio of drug to lipid was 1:40,the hydration solution was PBS(pH6.5),the density of R8 was 5%,and the density of DSPE-PEG2000 was 3%.The particle diameter of liposomes was 156±2 nm,PDI was 0.25,and the entrapment efficiency was 80.87%±8.9%.CONCLUSION The R8-modified paclitaxel-loaded liposomes were successfully prepared.
出处 《华西药学杂志》 CAS CSCD 北大核心 2012年第6期630-633,共4页 West China Journal of Pharmaceutical Sciences
关键词 八聚精氨酸 紫杉醇 血管平滑肌细胞 细胞摄取 Octaarginine Paclitaxel Vascular smooth muscle cell Cellular uptake
  • 相关文献

参考文献4

  • 1何蕾,王桂玲,张强.紫杉醇纳米乳剂的体内外考察[J].药学学报,2003,38(3):227-230. 被引量:41
  • 2Luciana LL,Subbu S. Adjustable paclitaxel release kinetics andits efficacy to inhibit smooth muscle cells proliferation [ J]. J ContrRel,2008,130:9 -14. 被引量:1
  • 3Kim DW,Kwon JS,Kim YG,e( al. Novel oral formulation of pacli-taxel inhibits neointimal hyperplasia in a rat carotid artery injurymodel[ J]. Circulation ,2004,109 : 1558 - 1563. 被引量:1
  • 4Ikramy AK,Kentaro Kogure,Shiroh Futaki,et al. Octaarginine -modified liposomes : Enhanced cellular uptake and controlled in-tracellular trafficking[ J]. Int J Pharm ,2008,354 ;39 - 48. 被引量:1

二级参考文献3

共引文献40

同被引文献19

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部